Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation. (Q46889020)
Jump to navigation
Jump to search
scientific article published in April 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation. |
scientific article published in April 2014 |
Statements
Genome-wide analysis of methotrexate pharmacogenomics in rheumatoid arthritis shows multiple novel risk variants and leads for TYMS regulation (English)
Sabyasachi Senapati
1 reference
Shalini Singh
Mitashree Das
Ashok Kumar
Rajiva Gupta
Uma Kumar
Sanjay Jain